Exact Mass: 384.2373

Exact Mass Matches: 384.2373

Found 271 metabolites which its exact mass value is equals to given mass value 384.2373, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Megestil

17alpha-hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate

C24H32O4 (384.23)

CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9660; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9556; ORIGINAL_PRECURSOR_SCAN_NO 9555 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9613; ORIGINAL_PRECURSOR_SCAN_NO 9611 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9650; ORIGINAL_PRECURSOR_SCAN_NO 9648 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9684; ORIGINAL_PRECURSOR_SCAN_NO 9681 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9604; ORIGINAL_PRECURSOR_SCAN_NO 9603 D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2814 CONFIDENCE standard compound; INTERNAL_ID 8750 D000970 - Antineoplastic Agents

Bufogein

5-[(1R,2S,4R,6R,7R,10S,11S,14S,16R)-14-hydroxy-7,11-dimethyl-3-oxapentacyclo[8.8.0.0(2),?.0(2),?.0(1)(1),(1)?]octadecan-6-yl]-2H-pyran-2-one

C24H32O4 (384.23)

Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide. Resibufogenin is a natural product found in Sclerophrys mauritanica, Bufo gargarizans, and other organisms with data available. Bufogenin is a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans; it is also one of the glycosides in the traditional Chinese medicine ChanSu, with potential cardiotonic activity. Although the mechanism of action of bufogenin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and has been shown to reduce blood pressure in a rat model of preeclampsia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents C471 - Enzyme Inhibitor Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.

Ibutilide

N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide

C20H36N2O3S (384.2447)

Ibutilide is only found in individuals that have used or taken this drug. It is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]Ibutilide is a pure class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca²⁺ channel blockers and potent inhibition of the cardiac rapid delayed rectifier K⁺ current, by binding within potassium channel pores. In other words, Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

Ethynodiol Diacetate

[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C24H32O4 (384.23)

Ethynodiol Diacetate is only found in individuals that have used or taken this drug. It is a synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. [PubChem]Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Ethynodiol Diacetate will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294

ST 24:5;O4

(22E)-12alpha-Hydroxy-3-oxochola-1,4,22-trien-24-oic Acid

C24H32O4 (384.23)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Same as: D01617 D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294

Estra-1,3,5(10)-triene-3,16alpha-diol dipropionate

C24H32O4 (384.23)

Acequinocyl

C24H32O4 (384.23)

An acetate ester consisting of 1,4-naphthoquinone bearing acetoxy and dodecyl substituents at positions 2 and 3 respectively.

Scillarenine

3,14-Dihydroxybufa-4,20,22-trienolide #

C24H32O4 (384.23)

(-)-Pyrifolidine

1-{12-ethyl-5,6-dimethoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-8-yl}ethan-1-one

C23H32N2O3 (384.2413)

(-)-Pyrifolidine is an alkaloid from Aspidosperma quebracho-blanco (quebracho). Alkaloid from Aspidosperma quebracho-blanco (quebracho).

7-[(1S,2R,3R,4R)-3-(3-Hydroxy-4-phenylpent-1-enyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid

C24H32O4 (384.23)

Bufogenin

5-{14-hydroxy-7,11-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-6-yl}-2H-pyran-2-one

C24H32O4 (384.23)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents

Estradiol dipropionate

15-methyl-5-(propanoyloxy)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-trien-14-yl propanoate

C24H32O4 (384.23)

Magestin

14-acetyl-2,8,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,8-dien-14-yl acetate

C24H32O4 (384.23)

Zipeprol

1-(2-Methoxy-2-phenyl)ethyl- 4-(2-hydroxy-3-methoxy-3-phenyl)propylpiperazine

C23H32N2O3 (384.2413)

R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

Gerronemin B

C24H32O4 (384.23)

5-hydroxy-4-isopropyl-1-methyl-7-(3-oxobutyl)bicyclo[4.1.0]hept-3-yl cinnamate

C24H32O4 (384.23)

Decahydro-alpha,4a-dimethyl-8-methylene-7-(1-oxo-3-phenylpropoxy)-2-naphthaleneacetic acid

C24H32O4 (384.23)

Vernoeggersic acid

C24H32O4 (384.23)

(-)-Albicanyl

3,4-dihydroxycinnamate

C24H32O4 (384.23)

8-(4-Hydroxycinnamoyl)-(4beta,5alpha,8alpha)-1(10)-Guaiaene-8,11-diol|<4S,5S,7S,8S>-8-p-Coumaroyloxy-1(10)-guaien-11-ol|[4S,5S,7S,8S]-8-p-Coumaroyloxy-1(10)-guaien-11-ol

C24H32O4 (384.23)

14.alpha.-Artebufogenin

C24H32O4 (384.23)

6-acetyl-8-benzoyltovarol

C24H32O4 (384.23)

plakortolide Q

C24H32O4 (384.23)

An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.

C24H32O4

C24H32O4 (384.23)

Rupestrinol orthocinnamate

C24H32O4 (384.23)

Aspidolimine

C23H32N2O3 (384.2413)

Vincaminoridine

C23H32N2O3 (384.2413)

Bufalone

C24H32O4 (384.23)

8-O-coumaroyltovarol

C24H32O4 (384.23)

2-Nor-1,2-secolycoseron

C24H32O4 (384.23)

Antheliolide B

C24H32O4 (384.23)

drimenyl trans-caffeate

C24H32O4 (384.23)

Desfurano-azadiradione|desfuranoazadiradione

C24H32O4 (384.23)

isobutyl 13-(1,3-benzdioxolo-5)trideca-2E,4E,12E-trienoate

C24H32O4 (384.23)

3beta,16beta-dihydroxy-bufa-8(14),20,22-trienolide

C24H32O4 (384.23)

Peyssonol B

C24H32O4 (384.23)

Estradiol butyrylacetate

C24H32O4 (384.23)

1-(2,6-Dihydroxy-4-methoxyphenyl)-11-phenyl-1-undecanone|11-phenylundecanoyl-2,6-dihydroxy-4-methoxybenzene

C24H32O4 (384.23)

6beta-(Cinnamoyloxy)eudesman-14-saeure

C24H32O4 (384.23)

epoxyjaeschkeanadiol t-cinnamate

C24H32O4 (384.23)

(all-Z)-form-1-(2,4,6-Trihydroxyphenyl)-6,9,12,15-octadecatetraen-1-one,|phloroglucinol

C24H32O4 (384.23)

lehualide E

C24H32O4 (384.23)

A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a (2E)-3-methyl-9-phenylnon-2-en-1-yl group at position 6. It has been isolated from the marine sponge of the genus Plakortis.

20(10->5)abeo-4,12-diacetoxy-4,5-secoabieta-5(10),6,8,11,13-pentaene|8-[4-(acetyloxy)-4-methylpentyl]-7-methyl-3-(1-methylethyl)naphthalen-2-yl acetate|diacetylcalocediol

C24H32O4 (384.23)

(1R,4E,8R,10R)-8-O-[(E)-p-coumaroyl]-1,10-epoxyhumula-4(5)-en-8-ol

C24H32O4 (384.23)

(1E,4R,5R,8R)-8-O-[(E)-p-coumaroyl]-4,5-epoxyhumula-1(10)-en-8-ol

C24H32O4 (384.23)

(1E,5R,8R)-8-O-[(E)-p-coumaroyl]-5-hydroxyhumula-1(10),4-(15)-dien-8-ol

C24H32O4 (384.23)

englerin B

C24H32O4 (384.23)

naviculyl caffeate

C24H32O4 (384.23)

triptowilfolide

C24H32O4 (384.23)

15-cinnamoyloxyplopanone

C24H32O4 (384.23)

robustol

C24H32O4 (384.23)

fekrynol

C24H32O4 (384.23)

palinurin

C24H32O4 (384.23)

3-benzoyl-6-acetyljuniferol|lyciferin D

C24H32O4 (384.23)

Resibufogenin

C24H32O4 (384.23)

Annotation level-1 Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.

Megestrol acetate

C24H32O4 (384.23)

D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D000970 - Antineoplastic Agents

[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

"[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate"

C24H32O4 (384.23)

MLS001074091-01!

C24H32O4 (384.23)

C23H32N2O3

NCGC00386084-01_C23H32N2O3_

C23H32N2O3 (384.2413)

C24H32O4_2-Propenoic acid, 3-phenyl-, (1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-(1-methylethyl)-11-oxabicyclo[8.1.0]undec-6-en-4-yl ester, (2E)

NCGC00385049-01_C24H32O4_2-Propenoic acid, 3-phenyl-, (1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-(1-methylethyl)-11-oxabicyclo[8.1.0]undec-6-en-4-yl ester, (2E)-

C24H32O4 (384.23)

C23H32N2O3

NCGC00386090-01_C23H32N2O3_

C23H32N2O3 (384.2413)

MMV008439

C23H32N2O3 (384.2413)

Zipeprol

C23H32N2O3 (384.2413)

5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol_major

C24H32O4 (384.23)

Ala Pro Val Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Ala Val Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Ala Val Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Gly Ile Pro Val

(2S)-2-{[(2S)-1-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Gly Ile Val Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Gly Leu Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Gly Leu Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Gly Pro Ile Val

(2S)-2-[(2S,3S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Gly Pro Leu Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Gly Pro Val Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylpentanoic acid

C18H32N4O5 (384.2373)

Gly Pro Val Leu

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-methylpentanoic acid

C18H32N4O5 (384.2373)

Gly Val Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Gly Val Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Gly Val Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C18H32N4O5 (384.2373)

Gly Val Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C18H32N4O5 (384.2373)

Ile Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Ile Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Ile Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Ile Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C18H32N4O5 (384.2373)

Ile Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Ile Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H32N4O5 (384.2373)

Leu Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Leu Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Leu Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Leu Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C18H32N4O5 (384.2373)

Leu Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Leu Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H32N4O5 (384.2373)

Pro Ala Val Val

(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]butanoic acid

C18H32N4O5 (384.2373)

Pro Gly Ile Val

(2S)-3-methyl-2-[(2S,3S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]butanoic acid

C18H32N4O5 (384.2373)

Pro Gly Leu Val

(2S)-3-methyl-2-[(2S)-4-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]butanoic acid

C18H32N4O5 (384.2373)

Pro Gly Val Ile

(2S,3S)-3-methyl-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]pentanoic acid

C18H32N4O5 (384.2373)

Pro Gly Val Leu

(2S)-4-methyl-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]pentanoic acid

C18H32N4O5 (384.2373)

Pro Ile Gly Val

(2S)-3-methyl-2-{2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}butanoic acid

C18H32N4O5 (384.2373)

Pro Ile Val Gly

2-[(2S)-3-methyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]acetic acid

C18H32N4O5 (384.2373)

Pro Leu Gly Val

(2S)-3-methyl-2-{2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}butanoic acid

C18H32N4O5 (384.2373)

Pro Leu Val Gly

2-[(2S)-3-methyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]acetic acid

C18H32N4O5 (384.2373)

Pro Val Ala Val

(2S)-3-methyl-2-[(2S)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanoic acid

C18H32N4O5 (384.2373)

Pro Val Gly Ile

(2S,3S)-3-methyl-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}pentanoic acid

C18H32N4O5 (384.2373)

Pro Val Gly Leu

(2S)-4-methyl-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}pentanoic acid

C18H32N4O5 (384.2373)

Pro Val Ile Gly

2-[(2S,3S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]acetic acid

C18H32N4O5 (384.2373)

Pro Val Leu Gly

2-[(2S)-4-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]acetic acid

C18H32N4O5 (384.2373)

Pro Val Val Ala

(2S)-2-[(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]propanoic acid

C18H32N4O5 (384.2373)

Val Ala Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Val Ala Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Val Gly Ile Pro

(2S)-1-[(2S,3S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Val Gly Leu Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Val Gly Pro Ile

(2S,3S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C18H32N4O5 (384.2373)

Val Gly Pro Leu

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C18H32N4O5 (384.2373)

Val Ile Gly Pro

(2S)-1-{2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Val Ile Pro Gly

2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H32N4O5 (384.2373)

Val Leu Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Val Leu Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H32N4O5 (384.2373)

Val Pro Ala Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylbutanoic acid

C18H32N4O5 (384.2373)

Val Pro Gly Ile

(2S,3S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylpentanoic acid

C18H32N4O5 (384.2373)

Val Pro Gly Leu

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-methylpentanoic acid

C18H32N4O5 (384.2373)

Val Pro Ile Gly

2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]acetic acid

C18H32N4O5 (384.2373)

Val Pro Leu Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]acetic acid

C18H32N4O5 (384.2373)

Val Pro Val Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]propanoic acid

C18H32N4O5 (384.2373)

Val Val Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C18H32N4O5 (384.2373)

Val Val Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C18H32N4O5 (384.2373)

9a-Fluoroallotetrahydrocortisol

C21H33FO5 (384.2312)

9a-Fluorotetrahydrocortisol

C21H33FO5 (384.2312)

12α-Hydroxy-3-oxochola-1,4,6-trien-24-oic Acid

C24H32O4 (384.23)

(22E)-12α-Hydroxy-3-oxochola-1,4,22-trien-24-oic Acid

C24H32O4 (384.23)

(-)-Pyrifolidine

1-{12-ethyl-5,6-dimethoxy-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6-trien-8-yl}ethan-1-one

C23H32N2O3 (384.2413)

Cardiogenin

3beta,14-dihydroxybufa-4,20,22-trienolide

C24H32O4 (384.23)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides

Bufohydrolide B

3beta,19-dihydroxy-5beta-bufa-14,20,22-trienolide

C24H32O4 (384.23)

Bufogarlide B

3alpha,19-dihydroxy-bufa-14,20,22-trienolide

C24H32O4 (384.23)

Bufogarlide C

3alpha,16alpha-dihydroxy-bufa-14,20,22-trienolide

C24H32O4 (384.23)

1-(2,4,6-Trihydroxyphenyl)-6Z,9Z,12Z,15Z-octadecatetraen-1-one

C24H32O4 (384.23)

6-Methylene Progesterone Acetate

C24H32O4 (384.23)

[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester

C23H32N2O3 (384.2413)

tert-butyl 4-(2-oxospiro[cyclohexane-1,3-indole]-1-yl)piperidine-1-carboxylate

C23H32N2O3 (384.2413)

Octaethylene glycol monomethyl ether

C17H36O9 (384.2359)

1-(2,6-Diisopropylphenyl)-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium chloride

C24H33ClN2 (384.2332)

dibenzyl-14-crown-4

C24H32O4 (384.23)

MMB-CHMINACA

C23H32N2O3 (384.2413)

MDMB-CHMICA

C23H32N2O3 (384.2413)

4-Farnesyl-3,5-dihydroxy-6-methylphthalide

C24H32O4 (384.23)

Desfuranoazadiradione

C24H32O4 (384.23)

A limonoid that is azadiradione in which the furanyl group at position 17 is replaced by a hydrogen. It has been isolated from Azadirachta indica.

plakortolide R

C24H32O4 (384.23)

An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.

Estra-1,3,5(10)-triene-3,16alpha-diol, dipropionate

C24H32O4 (384.23)

1-[4-(Benzyloxy)-3-methoxyphenyl]-5-hydroxydecan-3-one

C24H32O4 (384.23)

Ethynodiol Diacetate

C24H32O4 (384.23)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

Estradiol dipropionate

C24H32O4 (384.23)

(E)-7-[3-[(E)-3-hydroxy-4-phenylpent-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid

C24H32O4 (384.23)

[(1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-propan-2-yl-11-oxabicyclo[8.1.0]undec-6-en-4-yl] (E)-3-phenylprop-2-enoate

C24H32O4 (384.23)

acetic acid [(17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] ester

C24H32O4 (384.23)

[(2S,4aS,10aR)-6-acetyloxy-1,1,4a-trimethyl-7-propan-2-yl-2,3,4,10a-tetrahydrophenanthren-2-yl] acetate

C24H32O4 (384.23)

N-tert-butyl-2-[2-ethoxy-4-[(2-phenylethylamino)methyl]phenoxy]acetamide

C23H32N2O3 (384.2413)

N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide

C23H32N2O3 (384.2413)

N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide

C23H32N2O3 (384.2413)

2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone

C23H32N2O3 (384.2413)

Tandospirone cation

C21H30N5O2+ (384.2399)

[(8S,9R,10S,13R,14R,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

C24H32O4 (384.23)

(2Z,10Z,12E,14Z)-16-(3,5-dihydroxyphenyl)-2-ethylidenehexadeca-10,12,14-trienoic acid

C24H32O4 (384.23)

2-[2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethyl]-N,N,1-trimethylquinolin-1-ium-6-amine

C26H30N3+ (384.244)

(2R)-1-(dimethylamino)-2-[4-[(4-methoxy-3-methylphenyl)methyl]-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]propan-2-ol

C23H32N2O3 (384.2413)

[(8R,9R,10R,13S,14S,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

C24H32O4 (384.23)

Ibutilide

C20H36N2O3S (384.2447)

C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker